ASIT Biotech SA (EURONEXT:ASIT)
European company
Share Price Chart
- Chart currently unavailable -
Market Info - ASIT
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - ASIT
- Market Cap€7.830m
- SymbolEURONEXT:ASIT
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINBE0974289218
Company Profile
ASIT Biotech SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.ASIT Biotech SA is a clinical stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform.
Latest ASIT news
Currently there for this company. Visit our news hub for other news .